2015 Q1 Form 10-K Financial Statement
#000114420415019344 Filed on March 30, 2015
Income Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| Revenue | $0.00 | $40.14K | $50.00K |
| YoY Change | -100.0% | -93.65% | -50.0% |
| Cost Of Revenue | $0.00 | $0.00 | $30.00K |
| YoY Change | -100.0% | 200.0% | |
| Gross Profit | $0.00 | $40.14K | $20.00K |
| YoY Change | -100.0% | -70.72% | -77.78% |
| Gross Profit Margin | 100.0% | 40.0% | |
| Selling, General & Admin | $2.707M | $8.748M | $2.250M |
| YoY Change | 34.5% | -10.88% | 69.17% |
| % of Gross Profit | 21795.33% | 11250.0% | |
| Research & Development | $565.8K | $1.110M | $370.0K |
| YoY Change | 33.92% | 0.47% | -21.28% |
| % of Gross Profit | 2766.28% | 1850.0% | |
| Depreciation & Amortization | $64.25K | $480.3K | $120.0K |
| YoY Change | -48.64% | 1.56% | 20.0% |
| % of Gross Profit | 1196.66% | 600.0% | |
| Operating Expenses | $3.273M | $12.21M | $2.630M |
| YoY Change | 34.4% | 11.81% | 46.93% |
| Operating Profit | -$3.273M | -$12.17M | -$2.610M |
| YoY Change | 35.74% | 12.86% | 53.53% |
| Interest Expense | $1.784K | $15.77K | $0.00 |
| YoY Change | 138.18% | 4280.28% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$1.415K | $260.00 | |
| YoY Change | |||
| Pretax Income | -$3.274M | -$12.17M | -$2.760M |
| YoY Change | 35.77% | 12.85% | 61.4% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$3.335M | -$14.66M | -$2.760M |
| YoY Change | 38.31% | 35.91% | 61.4% |
| Net Earnings / Revenue | -36518.83% | -5520.0% | |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$23.86M | -$112.8M | -$27.60M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 25.40M shares | 18.02M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $9.700M | $8.500M | $6.300M |
| YoY Change | -41.57% | 34.07% | 270.59% |
| Cash & Equivalents | $9.728M | $8.500M | $6.342M |
| Short-Term Investments | |||
| Other Short-Term Assets | $300.0K | $830.0K | $300.0K |
| YoY Change | -70.0% | 196.43% | 200.0% |
| Inventory | $94.63K | $10.00K | $0.00 |
| Prepaid Expenses | $263.8K | $932.6K | |
| Receivables | $1.280M | $139.1K | |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $11.37M | $9.340M | $6.762M |
| YoY Change | -35.78% | 38.17% | 239.88% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $381.6K | $140.0K | $163.1K |
| YoY Change | 193.66% | -6.67% | 1.99% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $176.6K | $400.0K | $36.45K |
| YoY Change | -96.12% | -42.03% | -99.22% |
| Total Long-Term Assets | $2.436M | $2.420M | $5.247M |
| YoY Change | -47.98% | -53.9% | 8.49% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $11.37M | $9.340M | $6.762M |
| Total Long-Term Assets | $2.436M | $2.420M | $5.247M |
| Total Assets | $13.80M | $11.76M | $12.01M |
| YoY Change | -38.33% | -2.08% | 75.93% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $966.2K | $510.0K | $248.1K |
| YoY Change | 104.0% | 263.75% | |
| Accrued Expenses | $1.118M | $1.210M | $295.3K |
| YoY Change | 24.21% | 37.5% | -81.34% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $100.0K | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $3.487M | $2.260M | $1.402M |
| YoY Change | 222.22% | 61.43% | -15.09% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.487M | $2.260M | $1.402M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $3.519M | $2.270M | $1.407M |
| YoY Change | 219.91% | 60.99% | -17.21% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$38.51M | -$20.52M | |
| YoY Change | 67.96% | 110.82% | |
| Common Stock | $27.22K | $18.57K | |
| YoY Change | 11.41% | 43.77% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $10.28M | $9.500M | $10.60M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $13.80M | $11.76M | $12.01M |
| YoY Change | -38.33% | -2.08% | 75.93% |
Cashflow Statement
| Concept | 2015 Q1 | 2014 | 2013 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$3.335M | -$14.66M | -$2.760M |
| YoY Change | 38.31% | 35.91% | 61.4% |
| Depreciation, Depletion And Amortization | $64.25K | $480.3K | $120.0K |
| YoY Change | -48.64% | 1.56% | 20.0% |
| Cash From Operating Activities | -$2.999M | -$10.56M | -$2.650M |
| YoY Change | 15.33% | 19.54% | 37.31% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$70.00K | -$340.0K | -$90.00K |
| YoY Change | -30.0% | -30.61% | -30.77% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$66.04K | -$343.3K | -$90.00K |
| YoY Change | -33.97% | -29.95% | -30.77% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $4.292M | $13.16M | |
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 4.290M | 13.06M | 1.390M |
| YoY Change | -66.9% | -6.31% | -58.75% |
| NET CHANGE | |||
| Cash From Operating Activities | -$2.999M | -$10.56M | -2.650M |
| Cash From Investing Activities | -$66.04K | -$343.3K | -90.00K |
| Cash From Financing Activities | 4.290M | 13.06M | 1.390M |
| Net Change In Cash | -$3.065M | -$10.90M | -1.350M |
| YoY Change | -129.87% | -335.9% | -203.05% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$2.999M | -$10.56M | -$2.650M |
| Capital Expenditures | -$70.00K | -$340.0K | -$90.00K |
| Free Cash Flow | -$2.929M | -$10.22M | -$2.560M |
| YoY Change | 17.15% | 22.49% | 42.22% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
357532 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
444861 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
580645 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1401576 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
18574 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
31099691 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
8148 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
39788 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
6761860 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4395633 | USD |
| CY2013Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
651961 | USD |
| CY2014Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
351961 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24564058 | shares |
| CY2013Q4 | us-gaap |
Assets
Assets
|
12009047 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
248142 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
295310 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
48157 | USD |
| CY2013Q4 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
211493 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-20516614 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10601651 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12009047 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
144896 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
1630000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
|
200000 | USD |
| CY2014Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
203038 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
112393 | USD |
| CY2014 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
525954 | USD |
| CY2014 | us-gaap |
Cost Of Services
CostOfServices
|
340658 | USD |
| CY2013Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
152400 | USD |
| CY2013Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
19883 | USD |
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates:</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0px 0in 0.25in; FONT: 10pt Times New Roman, Times, Serif"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Reclassifications:</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in"> The prior period deferred financing costs have been reclassified to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in"> Certain prior period accrued expenses and current liabilities have been reclassified as accounts payable, payroll liabilities, and lease obligations to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
400000 | USD | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18574334 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24564058 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18574334 | shares |
| CY2013Q4 | us-gaap |
Prepaid Advertising
PrepaidAdvertising
|
0 | USD |
| CY2014Q4 | us-gaap |
Prepaid Advertising
PrepaidAdvertising
|
50000 | USD |
| CY2013Q4 | us-gaap |
Supplies
Supplies
|
0 | USD |
| CY2014Q4 | us-gaap |
Supplies
Supplies
|
14976 | USD |
| CY2013Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
112517 | USD |
| CY2014Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
87633 | USD |
| CY2013Q4 | us-gaap |
Deposit Assets
DepositAssets
|
36906 | USD |
| CY2014Q4 | us-gaap |
Deposit Assets
DepositAssets
|
25000 | USD |
| CY2013Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
31330 | USD |
| CY2013Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
168532 | USD |
| CY2014Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
522813 | USD |
| CY2013Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
93665 | USD |
| CY2014Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
93665 | USD |
| CY2013Q4 | atos |
Capitalized New Product Development Costs
CapitalizedNewProductDevelopmentCosts
|
15000 | USD |
| CY2014Q4 | atos |
Capitalized New Product Development Costs
CapitalizedNewProductDevelopmentCosts
|
0 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
114050 | USD |
| CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
258946 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
82970 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
4794853 | USD |
| CY2013Q4 | us-gaap |
Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
|
0 | USD |
| CY2013Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
105839 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
505059 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
213776 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
224804 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
193443 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
169015 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
169015 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
950592 | USD |
| CY2013Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
408362 | USD |
| CY2014Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
752828 | USD |
| CY2014Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
109653 | USD |
| CY2014Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
194224 | USD |
| CY2014Q4 | atos |
Total Shares Authorized
TotalSharesAuthorized
|
85000000 | shares |
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
6033426 | shares |
| CY2014Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
15.00 | |
| CY2014Q2 | atos |
Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
|
0.020 | pure |
| CY2014Q2 | atos |
Entitled To Receive Worth Of Common Stock
EntitledToReceiveWorthOfCommonStock
|
30.00 | |
| CY2013 | atos |
Product Sales
ProductSales
|
223440 | USD |
| CY2014 | atos |
Product Sales
ProductSales
|
0 | USD |
| CY2013 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
632558 | USD |
| CY2013 | us-gaap |
Cost Of Services
CostOfServices
|
105764 | USD |
| CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
239755 | USD |
| CY2014 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
0 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
345519 | USD |
| CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
340658 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
137093 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
185296 | USD |
| CY2013 | us-gaap |
Selling Expense
SellingExpense
|
1257791 | USD |
| CY2014 | us-gaap |
Selling Expense
SellingExpense
|
1271705 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1105110 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2577465 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8558835 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8625917 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
10921736 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
14827713 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10784643 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14642417 | USD |
| CY2013 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
295 | USD |
| CY2014 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
260 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
360 | USD |
| CY2014 | us-gaap |
Interest Expense
InterestExpense
|
15769 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-10784708 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14657926 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10784708 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14657926 | USD |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.70 | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.61 | |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
15484414 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
24038578 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7034269 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9709060 | shares |
| CY2014Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2013Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
6092161 | USD |
| CY2014Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
8250718 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
499267 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
478210 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
119333 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
13439 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1123688 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2282719 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2426669 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
873754 | shares |
| CY2014 | atos |
Stock Issued During Period Shares Stock Options Exercised1
StockIssuedDuringPeriodSharesStockOptionsExercised1
|
160000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3675634 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1391749 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3380169 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.43 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.45 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.29 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.25 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.86 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.34 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
2.95 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y1M10D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y3M22D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y4D | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
282063 | USD |
| CY2014 | atos |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue
|
21540 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
69388 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
344000 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
37878 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
301945 | USD |
| CY2014Q2 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
22728 | shares |
| CY2013Q4 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
24510 | shares |
| CY2014Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
50000 | USD |
| CY2013Q4 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
50000 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1443760 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
698657 | USD |
| CY2014Q2 | atos |
Directors Compensation Paid
DirectorsCompensationPaid
|
35000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P2Y10M2D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1422750 | shares |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
2283885 | shares |
| CY2014Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1506667 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5175535 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
|
12303745 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
|
14002162 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
180252 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | USD |
| CY2013 | atos |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
1621182 | USD |
| CY2014 | atos |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
32000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1443760 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
698657 | USD |
| CY2013 | us-gaap |
Profit Loss
ProfitLoss
|
-10784708 | USD |
| CY2014 | us-gaap |
Profit Loss
ProfitLoss
|
-14657926 | USD |
| CY2013 | atos |
Common Shares Issued For Services
CommonSharesIssuedForServices
|
178280 | USD |
| CY2014 | atos |
Common Shares Issued For Services
CommonSharesIssuedForServices
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1443760 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
698657 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
472934 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
564456 | USD |
| CY2013 | atos |
Bad Debt Expense
BadDebtExpense
|
354861 | USD |
| CY2014 | atos |
Bad Debt Expense
BadDebtExpense
|
209288 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
352267 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
368174 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
149946 | USD |
| CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
39788 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
57994 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
51581 | USD |
| CY2013 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
|
-11747 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-58583 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
346215 | USD |
| CY2013 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
268480 | USD |
| CY2014 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
476060 | USD |
| CY2013 | atos |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
48157 | USD |
| CY2014 | atos |
Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
|
-45674 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-704372 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
149551 | USD |
| CY2013 | atos |
Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
|
211493 | USD |
| CY2014 | atos |
Increase Decrease In Product Recall Liabilities
IncreaseDecreaseInProductRecallLiabilities
|
-211493 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-8377 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
34080 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-8830044 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-10555450 | USD |
| CY2013 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
244442 | USD |
| CY2014 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
146058 | USD |
| CY2013 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
245373 | USD |
| CY2014 | us-gaap |
Payments To Acquire Software
PaymentsToAcquireSoftware
|
197199 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-489815 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-343257 | USD |
| CY2013 | atos |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
13936823 | USD |
| CY2014 | atos |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
13155745 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
13936823 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
13057264 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
4616964 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2158557 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1725197 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
360 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
15769 | USD |
| CY2013 | atos |
Non Cash Reclassification Of Furniture And Equipment To Prepaid Expenses
NonCashReclassificationOfFurnitureAndEquipmentToPrepaidExpenses
|
0 | USD |
| CY2014 | atos |
Non Cash Reclassification Of Furniture And Equipment To Prepaid Expenses
NonCashReclassificationOfFurnitureAndEquipmentToPrepaidExpenses
|
15000 | USD |
| CY2013 | atos |
Common Stock Issued For Commitment Fee In Stock Purchase Agreement
CommonStockIssuedForCommitmentFeeInStockPurchaseAgreement
|
2387250 | USD |
| CY2014 | atos |
Common Stock Issued For Commitment Fee In Stock Purchase Agreement
CommonStockIssuedForCommitmentFeeInStockPurchaseAgreement
|
0 | USD |
| CY2014 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0px 0in 0in; FONT: 10pt Times New Roman, Times, Serif"> <b>NOTE 1: NATURE OF OPERATIONS</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Atossa Genetics Inc. (the “Company”) was incorporated on April 30, 2009 in the State of Delaware. The Company’s operations began in December 2008 with the negotiations for the acquisition of the Mammary Aspirate Specimen Cytology Test System, or the MASCT System, patent rights and assignments and the FDA clearance for marketing, which acquisition was completed in January 2009. The Company was formed to develop and market the MASCT System, which is a medical device that collects specimens of nipple aspirate fluid (NAF). The Company’s fiscal year ends on December 31.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px 0in 0in"> In December 2011, the Company established the National Reference Laboratory for Breast Health, Inc., or NRLBH, as a wholly-owned subsidiary. NRLBH is the Company’s CLIA-certified laboratory which performs the Company’s NAF cytology test on NAF specimens including those collected with the MASCT System. The current version of the MASCT System is called the ForeCYTE Breast Aspirator. The NRLBH is providing other test services, including the pharmacogenomics test, and is developing other tests such as the ArgusCYTE test on blood samples from breast cancer survivors to detect circulating tumor cells.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px 0in 0in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px 0in 0in"> In September 2012, the Company acquired the assets of Acueity Healthcare, Inc. (“Acueity”). The purchased assets included the intellectual property rights related to the Viaduct Miniscope and accessories, the Manoa Breast Biopsy system, the Excisor Bioptome, the Acueity Medical Light Source, the Viaduct Microendoscope and accessories, and cash in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">400,000</font>. The microendoscopes are less than 0.9 mm outside diameter and can be inserted into a milk duct. This permits a physician to pass a microendoscope into the milk duct system of the breast and view the duct system via fiberoptic video images. Abnormalities that are visualized can then be biopsied from inside the duct with the biopsy tools that are inserted adjacent to the microendoscope. The patents relate to intraductal diagnostic and therapeutic devices and methods of use. The Company did not, however, acquire an inventory of these diagnostic tools, manufacturing capabilities or any personnel to market and sell the tools. The Company cannot provide any assurance that it will be successful commercializing these tools.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
36446 | USD |
| CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
48193 | USD |
| CY2013Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
9681 | USD |
| CY2014Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
76025 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
1407396 | USD |
| CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
2265875 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
5820 | USD |
| CY2014Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
49216 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
2483 | USD |
| CY2013 | atos |
Loss On Reduction Of Inventory To Lower Of Cost Or Market
LossOnReductionOfInventoryToLowerOfCostOrMarket
|
149946 | USD |
| CY2014 | atos |
Loss On Reduction Of Inventory To Lower Of Cost Or Market
LossOnReductionOfInventoryToLowerOfCostOrMarket
|
0 | USD |
| CY2013 | atos |
Stock Issued During Period Value For Capital Raising Fees
StockIssuedDuringPeriodValueForCapitalRaisingFees
|
-651961 | USD |
| CY2014 | atos |
Stock Issued During Period Value For Capital Raising Fees
StockIssuedDuringPeriodValueForCapitalRaisingFees
|
1378417 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
9924 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
200000 | USD |
| CY2013 | atos |
Loss On Reduction Of Inventory
LossOnReductionOfInventory
|
149946 | USD |
| CY2014 | atos |
Loss On Reduction Of Inventory
LossOnReductionOfInventory
|
0 | USD |
| CY2013 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
158292 | USD |
| CY2014 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
2352626 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
ATOSSA GENETICS INC | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001488039 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
32864598 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
ATOS | |
| CY2015Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
25396124 | shares |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
354861 | USD |
| CY2014Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
564149 | USD |
| CY2013 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
354861 | USD |
| CY2014 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
209288 | USD |
| CY2013Q4 | atos |
Prepaid Maintenance And Support Service Fee
PrepaidMaintenanceAndSupportServiceFee
|
131204 | USD |
| CY2014Q4 | atos |
Prepaid Maintenance And Support Service Fee
PrepaidMaintenanceAndSupportServiceFee
|
38268 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
13439 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6144800 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9772300 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
546600 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
732400 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2014 | atos |
Operating Loss Carryforwards Description
OperatingLossCarryforwardsDescription
|
2029 through 2034 | |
| CY2014 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
The Company files income tax returns in the U.S. The Company is subject to tax examinations for the 2011 tax year and beyond. | |
| CY2013 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
0 | USD |
| CY2014 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
2352626 | USD |
| CY2014Q4 | atos |
Working Capital
WorkingCapital
|
6900000 | USD |
| CY2014 | atos |
Estimated Annualized Forfieture Rate
EstimatedAnnualizedForfietureRate
|
0.10 | pure |
| CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
0 | USD |
| CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
98481 | USD |
| CY2013 | atos |
Non Cash Furniture And Fixtures Acquired Through Capital Lease
NonCashFurnitureAndFixturesAcquiredThroughCapitalLease
|
0 | USD |
| CY2014 | atos |
Non Cash Furniture And Fixtures Acquired Through Capital Lease
NonCashFurnitureAndFixturesAcquiredThroughCapitalLease
|
206702 | USD |
| CY2014Q4 | us-gaap |
Capital Leased Assets Gross
CapitalLeasedAssetsGross
|
206702 | USD |
| CY2014 | atos |
Amortization Of Capital Lease Equipment Straight Line Basis
AmortizationOfCapitalLeaseEquipmentStraightLineBasis
|
P5Y | |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
120700 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
191900 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
16400 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
900 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
|
16400 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
|
30400 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
|
228100 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
51000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
48400 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
|
204500 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
|
499700 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
8900 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
29000 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
841800 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
53800 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
|
53800 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
300 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
|
6783100 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
|
11397400 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
3200 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
3200 | USD |
| CY2013 | atos |
Expected Federal Tax Expense Benefit
ExpectedFederalTaxExpenseBenefit
|
3774648 | USD |
| CY2014 | atos |
Expected Federal Tax Expense Benefit
ExpectedFederalTaxExpenseBenefit
|
4983700 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
4363 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
9000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
36100 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
3770285 | USD |
| CY2014 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4938600 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
28700000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
1443760 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
698657 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
277197 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
616478 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4900692 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2033038 | USD |
| CY2013 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
121201 | USD |
| CY2014 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
149174 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6987600 | USD |
| CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11897100 | USD |
| CY2013 | atos |
Other Research And Development And General And Administration Expenses
OtherResearchAndDevelopmentAndGeneralAndAdministrationExpenses
|
335502 | USD |
| CY2014 | atos |
Other Research And Development And General And Administration Expenses
OtherResearchAndDevelopmentAndGeneralAndAdministrationExpenses
|
377170 | USD |
| CY2013 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
214301 | USD |
| CY2014 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
227996 | USD |
| CY2013 | atos |
Diagnostic Testing Service
DiagnosticTestingService
|
409118 | USD |
| CY2014 | atos |
Diagnostic Testing Service
DiagnosticTestingService
|
525954 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
|
76025 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
|
49216 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
|
0 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
|
0 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
|
0 | USD |
| CY2014Q4 | us-gaap |
Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
|
125241 | USD |
| CY2014Q3 | us-gaap |
Other Commitments Description
OtherCommitmentsDescription
|
On September 1, 2014, the NRLBH entered into a three year agreement with TME Research LLC (TME) which requires TME to provide to the NRLBH 100 tissue specimens in connection with the development of the NextCYTE test. Fees payable to TME under the agreement includes $99,600 up front, $31,500 upon supplying the first 25 specimens and $31,500 at the time of final delivery of all specimens. The agreement is terminable with 60 days prior written notice or immediately upon a material breach. | |
| CY2014Q3 | atos |
Upfront Fee Payable Under Targeted Medical Education Agreement
UpfrontFeePayableUnderTargetedMedicalEducationAgreement
|
99600 | USD |
| CY2014Q3 | atos |
Fee Payable Upon Supply Of First Specimen Under Targeted Medical Education Agreement
FeePayableUponSupplyOfFirstSpecimenUnderTargetedMedicalEducationAgreement
|
31500 | USD |
| CY2014Q3 | atos |
Fee Payable Upon Final Delivery Under Targeted Medical Education Agreement
FeePayableUponFinalDeliveryUnderTargetedMedicalEducationAgreement
|
31500 | USD |
